Mouse HVEM/TNFRSF14 PE-conjugated Antibody Summary
Accession # NP_849262
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Detection of HVEM/TNFRSF14 in HEK293 human embryonic kidney cell line transfected with mouse HVEM/TNFRSF14 and eGFP by Flow Cytometry. HEK293 human embryonic kidney cell line transfected with either (A) mouse HVEM/TNFRSF14 or (B) irrelevant transfectants and eGFP was stained with Rabbit Anti-Mouse HVEM/TNFRSF14 PE-conjugated Monoclonal Antibody (Catalog # FAB2516P). Quadrant markers were set based on control antibody staining (Catalog # IC1051P). View our protocol for Staining Membrane-associated Proteins.
Preparation and Storage
- 12 months from date of receipt, 2 to 8 °C as supplied.
HVEM (Herpesvirus Entry Mediator) is a type I membrane protein that is TNF receptor superfamily member 14 (TNFRSF14) (1). The mouse HVEM cDNA encodes a 275 amino acid (aa) protein. It contains a 36 aa signal peptide, a 170 aa extracellular domain with three cysteine rich domains (CRD), a 24 aa transmembrane region and a 45 aa cytoplasmic tail with a TRAF interaction domain (1). HVEM expression is highest on naïve, memory and regulatory T cells, but declines during T cell activation (2, 3). It is present at low levels on most resting leukocytes (4). HVEM is a receptor for the IGSF member BTLA (B and T Lymphocyte Attenuator), CD160, and the TNF family ligand LIGHT (2, 9). HVEM and BTLA are constitutively expressed on T cells, while LIGHT is generally considered to be inducible upon TCR activation. In the absence of activation, HVEM and BTLA interact monomerically, either in cis, or in trans. A same cell (or cis) interaction likely promotes general cell survival, while a between cell (or trans) interaction promotes a state of lymphocyte inactivity through the BTLA cytoplasmic domain. Following T cell activation, LIGHT appears and disrupts existing HVEM-BTLA bonds. A LIGHT-HVEM trimer now forms in trans, initiating HVEM-mediated NF kappa B signaling and a proinflammatory response (10). BTLA and LIGHT interactions are not mutually exclusive, but BTLA appears dominant (4, 6, 7). The herpesvirus envelope glycoprotein gD, which binds HVEM CRD1 to initiate membrane fusion, can antagonize both BTLA and LIGHT binding (1, 6, 7, 9). Human, but not mouse, HVEM can also bind lymphotoxin a within CRD2 3 (9, 11). Graft‑vs‑host disease and Th1 type intestinal inflammation can be ameliorated by interrupting T cell LIGHT/HVEM interactions, while disruption of BTLA/HVEM interaction promotes intestinal inflammation (12-14). Mouse HVEM ECD shares 89% and 53% aa identity with rat and human HVEM, respectively. Mouse HVEM can recognize human BTLA and LIGHT, but human HVEM does not recognize mouse ligands (2, 11).
- Hsu, H. et al. (1997) J. Biol. Chem. 272:13471.
- Sedy, J.R. et al. (2005) Nat. Immunol. 6:90.
- Tao, R. et al. (2008) J. Immunol. 180:6649.
- Wang, Y. et al. (2005) J. Clin. Invest. 115:711.
- Nelson, C.A. et al. (2008) J. Immunol. 180:940.
- Gonzales, L.C. et al. (2005) Proc. Natl. Acad Sci. USA 102:1116.
- Compaan, D.M. et al. (2005) J. Biol. Chem. 280:39553.
- Cai, G. et al. (2008) Nat. Immunol. 9:176.
- Mauri, D.N. et al. (1998) Immunity 8:21.
- Ware, C.F. (2008) Immunol. Rev. 223:186.
- Bossen, C. et al. (2006) J. Biol. Chem. 281:13964.
- Xu, Y. et al. (2007) Blood 109:4097.
- Wang, J. et al. (2005) J. Immunol. 174:8173.
- Steinberg, M.W. et al. (2008) J. Exp. Med. 205:1463.
No product specific FAQs exist for this product, however you mayView all Antibody FAQs
Reviews for Mouse HVEM/TNFRSF14 PE-conjugated Antibody
There are currently no reviews for this product. Be the first to review Mouse HVEM/TNFRSF14 PE-conjugated Antibody and earn rewards!
Have you used Mouse HVEM/TNFRSF14 PE-conjugated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image